THERANOSTICS 2016* , ,
Presentations this author is a contributor to:
PET/CT based dosimetry for 90Y-DOTATOC treatment of neuroendocrine cancer (#13)
3:30 PM
John Sunderland
Optimising Peptide Receptor Radionuclide Therapy (PRRT) - (submitted abstracts)